DK1896031T3 - Thiazolopyrimidiner til anvendelse i terapi - Google Patents

Thiazolopyrimidiner til anvendelse i terapi

Info

Publication number
DK1896031T3
DK1896031T3 DK06744265T DK06744265T DK1896031T3 DK 1896031 T3 DK1896031 T3 DK 1896031T3 DK 06744265 T DK06744265 T DK 06744265T DK 06744265 T DK06744265 T DK 06744265T DK 1896031 T3 DK1896031 T3 DK 1896031T3
Authority
DK
Denmark
Prior art keywords
therapy
thiazolopyrimidines
alkyl
group
nhalkyl
Prior art date
Application number
DK06744265T
Other languages
Danish (da)
English (en)
Inventor
Fei-Yeu Zhao
Alistair Kerr Dixon
Johnathan Mark Treherne
Chizuko Koseki
Original Assignee
Sosei Group Corp
Neurosolutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei Group Corp, Neurosolutions Ltd filed Critical Sosei Group Corp
Application granted granted Critical
Publication of DK1896031T3 publication Critical patent/DK1896031T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK06744265T 2005-06-20 2006-06-19 Thiazolopyrimidiner til anvendelse i terapi DK1896031T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0512554.7A GB0512554D0 (en) 2005-06-20 2005-06-20 Compounds for use in therapy
PCT/GB2006/002248 WO2006136806A1 (en) 2005-06-20 2006-06-19 Thiazolopyrimidines for use in therapy

Publications (1)

Publication Number Publication Date
DK1896031T3 true DK1896031T3 (da) 2009-05-11

Family

ID=34855848

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06744265T DK1896031T3 (da) 2005-06-20 2006-06-19 Thiazolopyrimidiner til anvendelse i terapi

Country Status (20)

Country Link
US (1) US8349845B2 (zh)
EP (1) EP1896031B1 (zh)
JP (1) JP5055474B2 (zh)
KR (1) KR20080076897A (zh)
CN (1) CN101355947B (zh)
AT (1) ATE419853T1 (zh)
AU (1) AU2006260714B2 (zh)
BR (1) BRPI0614386A2 (zh)
CA (1) CA2612865C (zh)
DE (1) DE602006004735D1 (zh)
DK (1) DK1896031T3 (zh)
ES (1) ES2323981T3 (zh)
GB (1) GB0512554D0 (zh)
HK (1) HK1108842A1 (zh)
IL (1) IL188061A0 (zh)
NO (1) NO20080049L (zh)
NZ (1) NZ564170A (zh)
PT (1) PT1896031E (zh)
WO (1) WO2006136806A1 (zh)
ZA (1) ZA200711062B (zh)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564591A (en) * 1978-11-10 1980-05-15 Teijin Ltd Thiazolo 3, 2-a pyrimidine derivative, its preparation, and drug comprising it
JPS5566592A (en) * 1978-11-13 1980-05-20 Teijin Ltd 7-alkoxythiazolo 3,2-a pyrimidine derivative, its preparation, and drug containing the same
WO1981003174A1 (en) * 1980-04-28 1981-11-12 Teijin Ltd Thiazolo(3,2-a)pyrimidine derivatives,process for preparing same,and drug containing same

Also Published As

Publication number Publication date
BRPI0614386A2 (pt) 2011-03-22
KR20080076897A (ko) 2008-08-20
JP5055474B2 (ja) 2012-10-24
ATE419853T1 (de) 2009-01-15
CN101355947A (zh) 2009-01-28
EP1896031A1 (en) 2008-03-12
CA2612865A1 (en) 2006-12-28
CN101355947B (zh) 2013-06-05
US8349845B2 (en) 2013-01-08
US20100216819A1 (en) 2010-08-26
GB0512554D0 (en) 2005-07-27
DE602006004735D1 (de) 2009-02-26
HK1108842A1 (en) 2008-05-23
NZ564170A (en) 2011-03-31
ES2323981T3 (es) 2009-07-28
NO20080049L (no) 2008-01-17
IL188061A0 (en) 2011-08-01
WO2006136806A1 (en) 2006-12-28
AU2006260714B2 (en) 2008-11-13
CA2612865C (en) 2013-03-26
EP1896031B1 (en) 2009-01-07
PT1896031E (pt) 2009-04-15
JP2008543918A (ja) 2008-12-04
AU2006260714A1 (en) 2006-12-28
ZA200711062B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
TR201900306T4 (tr) Mek inhibitörlerini kullanma yöntemleri.
BR112014003237A2 (pt) compostos de indazol, composições e métodos de uso
ME01992B (me) Jedinjenje diarilhidantoina
ECSP067080A (es) DIFENILIMIDAZOPIRIMIDINA Y AMINAS IMIDAZOL COMO INHIBIDORES DE ß-SECRETASA
GEP20125425B (en) Biaryl ether urea compounds
ATE536349T1 (de) In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
SE0301882D0 (sv) New use I
SE0301886D0 (sv) New use V
SE0301888D0 (sv) New use VII
ATE440833T1 (de) Antithrombotische diamide
WO2008022024A3 (en) Imidazole amines as inhibitors of beta-secretase
EA200801997A1 (ru) Новые соединения
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
CY1109743T1 (el) Παραγωγα των 2-βενζοϋλο-ιμιδαζοπυριδινων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
EA200701813A1 (ru) Новые амидозамещенные 6-фенилфенантридины
TW200611693A (en) GPR35 and modulators thereof for the treatment of metabolic-related disorders
AR043327A1 (es) Uso de inhibidores de quinurenina 3- hidroxilasa para el tratamiento de la diabetes
ATE369366T1 (de) S-tenatoprazolnatrium-monohydrat-salz und dessen verwendung in form eines protonenpumpenhemmers
SE0200198D0 (sv) New use
DK1896031T3 (da) Thiazolopyrimidiner til anvendelse i terapi